Get started
Author

H Errihani -

Observed names: Errihani H, H. Errihani, Hassan Errihani
Observed institution: Institut National d'Oncologie
OpenAlex ID: A5077362881
335eP Pathologic complete response after neoadjuvant therapy in HER2-positive breast cancer: A Moroccan real-world study
2026 · B. Atmane, J. El Afeya, et al. · ESMO Open
PDF
Observational study of trastuzumab biosimilar in patients with HER2-positive breast cancer under routine clinical practice conditions in Morocco
2026 · Hassan Errihani, Narjiss Berrada, et al. · BMC Cancer
257eP Primary bone sarcomas in Morocco: Survival outcomes from a tertiary care center
2026 · B. Atmane, S. Toumi, et al. · ESMO rare cancers.
Pre-therapeutic onco-geriatric assessment optimizes chemotherapy in elderly moroccans with advanced bladder cancer
2025 · S. Kriouile, S. Lkhoyaali, et al. · European Urology Open Science
Epithelial-Myoepithelial Carcinoma of Minor Salivary Gland with Distant Metastasis: A Case Report
2024 · Hajar Lemsyeh -, K Taleb -, et al. · International Journal For Multidisciplinary Research
PDF
91P Management challenges of extremity sarcomas in under-resourced settings: The first survey-based study in Morocco
2023 · S. Kharmoum, A. Najdi, et al. · ESMO Open
Meningeal and Bone Metastases from Myoepithelial Carcinoma Ex-pleomorphic Adenoma of the Parotid: CASE REPORT
2021 · Razine S, Najem S, et al. · World Journal of Innovative Research
PDF
Métastases choroïdiennes révélatrice d’un carcinome vésiculaire de la thyroïde
2010 · M. Kairouani, S. Sekkate, et al. · Cancer/Radiothérapie
Works count: 8
Citation count:
H-index:
I10-index:
Year
Topic
Type